Our mission is to deliver mRNA technology innovations to revolutionize future therapies and the prevention of many diseases. We invent, develop, manufacture and apply our solutions for the benefit of pharmaceutical partners, and to improve people’s lives. With passion, ExploRNA Therapeutics develops ground-breaking innovations of mRNA as a therapeutic platform, applies those solutions in unique therapeutic programs, and delivers technology, therapeutic platform, and therapies to pharmaceutical partners. The future of healthcare belongs to therapeutic mRNA.
Location: Poland, Masovian Voivodeship, Warsaw
Employees: 11-50
Total raised: $813.6K
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.12.2022 | Grant | $813.6K | Bill &... |
Mentions in press and media 2
| Date | Title | Description |
| 09.12.2022 | ExPLoRNA Therapeutics Receives $813.578 From Bill & Melinda Gates Foundation | ExPLoRNA Therapeutics, a Warsaw, Poland-based biotech company, raised $813.578 from Bill & Melinda Gates Foundation. Led by CEO Jacek Jemielity, ExPLoRNA Therapeutics specializes in novel cap analogs, the starting part of mRNA that is c... |
| 09.12.2022 | Polish biotech ExPLoRNA Therapeutics gets $800k from Bill & Melinda Gates Foundation | Polish biotech ExPLoRNA Therapeutics gets $800k from Bill & Melinda Gates Foundation 09 December, 2022, 17:20 Mariia Denysiuk --> --> --> -->--> --> --> --> --> --> --> --> --> The Warsaw-based ... |